関連する実験動画
Updated: Jan 7, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
顔マスクサンプリングを用いた非侵襲的な肺結核診断:成人を対象とした前向き研究
Dariusz Woelk1, Lennard Meiwes2, Nelly Ciobanu3
1Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany; Clinical Tuberculosis Unit, German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Germany.
まとめ
顔マスクサンプリング(FMS)は、肺結核(TB)の非侵襲的な検出方法を提供する。このアプローチは、成人におけるTBのより迅速な検出のための従来の診断法を補完する潜在的な付加的収量を示した。
科学分野:
- 肺医学
- 感染症
- 診断微生物学
背景:
- 肺結核(TB)の喀痰ベースの検査は感度が高いが、患者の喀痰産生を必要とする。
- 喀痰を産生できない場合、気管支鏡検査などの侵襲的な処置が必要になる場合がある。
- 顔マスクサンプリング(FMS)は、TB診断のための非侵襲的な代替法を提示する。
研究 の 目的:
- 肺結核検出のための非侵襲的方法としてのFMSの診断精度の評価。
- FMSと従来の喀痰ベースの診断方法との性能比較。
主な方法:
- モルドバで確認された肺結核成人患者を登録した。
- 顔マスクサンプリング(FMS)を実施し、サンプルをXpert MTB/RIF Ultraを用いて分析した。
- FMSの診断性能を喀痰Xpert MTB/RIF Ultraおよび培養と比較した。
主要な成果:
- 登録された117人の成人患者のうち、88.0%が従来の検査法で陽性と判定された。顔マスクサンプリング(FMS)は陽性症例の59.2%を検出した。FMSの感度は喀痰培養に対して64.4%、喀痰Xpert MTB/RIF Ultraに対して58.3%であった。
- 登録された117人の成人患者のうち、88.0%が従来の検査法で陽性と判定された。顔マスクサンプリング(FMS)は陽性症例の59.2%を検出した。FMSの感度は喀痰培養に対して64.4%、喀痰Xpert MTB/RIF Ultraに対して58.3%であった。
結論:
- 顔マスクサンプリング(FMS)は、肺結核診断において潜在的な付加的収量を示す。
- FMSは、従来の診断法と並んで有用な補完的ツールとして機能することができる。
- この非侵襲的方法は、成人における肺結核の迅速な検出を強化する可能性がある。
関連する概念動画
Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884

